Identification and functional analysis of 9p24 amplified genes in human breast cancer (original) (raw)
Akiyama M, Ishida N, Ogawa T, Yogo K, Takeya T . (2005). Molecular cloning and functional analysis of a novel Cx43 partner protein CIP150. Biochem Biophys Res Commun335: 1264–1271. ArticleCASPubMed Google Scholar
Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J et al. (2010). The landscape of somatic copy-number alteration across human cancers. Nature463: 899–905. ArticleCASPubMedPubMed Central Google Scholar
Bronner C, Achour M, Arima Y, Chataigneau T, Saya H, Schini-Kerth VB . (2007). The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol Ther115: 419–434. ArticleCASPubMed Google Scholar
Chan DW, Wang Y, Wu M, Wong J, Qin J, Zhao Y . (2009). Unbiased proteomic screen for binding proteins to modified lysines on histone H3. Proteomics9: 2343–2354. ArticleCASPubMedPubMed Central Google Scholar
Chan TA, Glockner S, Yi JM, Chen W, Van Neste L, Cope L et al. (2008). Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med5: e114. ArticlePubMedPubMed Central Google Scholar
Chen Z, Zang J, Whetstine J, Hong X, Davrazou F, Kutateladze TG et al. (2006). Structural insights into histone demethylation by JMJD2 family members. Cell125: 691–702. ArticleCASPubMed Google Scholar
Cloos PA, Christensen J, Agger K, Maiolica A, Rappsilber J, Antal T et al. (2006). The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature442: 307–311. ArticleCASPubMed Google Scholar
Ding L, Ellis MJ, Li S, Larson DE, Chen K, Wallis JW et al. (2010). Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature464: 999–1005. ArticleCASPubMedPubMed Central Google Scholar
el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell75: 817–825. ArticleCASPubMed Google Scholar
Esteller M . (2007). Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet8: 286–298. ArticleCASPubMed Google Scholar
Fukushige S, Matsubara K, Yoshida M, Sasaki M, Suzuki T, Semba K et al. (1986). Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Mol Cell Biol6: 955–958. ArticleCASPubMedPubMed Central Google Scholar
Garcia MJ, Pole JC, Chin SF, Teschendorff A, Naderi A, Ozdag H et al. (2005). A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene24: 5235–5245. ArticleCASPubMed Google Scholar
Garcia-Rudaz C, Luna F, Tapia V, Kerr B, Colgin L, Galimi F et al. (2007). Fxna, a novel gene differentially expressed in the rat ovary at the time of folliculogenesis, is required for normal ovarian histogenesis. Development134: 945–957. ArticleCASPubMed Google Scholar
Gelsi-Boyer V, Orsetti B, Cervera N, Finetti P, Sircoulomb F, Rouge C et al. (2005). Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol Cancer Res3: 655–667. ArticleCASPubMed Google Scholar
Giefing M, Zemke N, Brauze D, Kostrzewska-Poczekaj M, Luczak M, Szaumkessel M et al. (2011). High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma. Genes Chromosomes Cancer50: 154–166. ArticleCASPubMed Google Scholar
Han W, Jung EM, Cho J, Lee JW, Hwang KT, Yang SJ et al. (2008). DNA copy number alterations and expression of relevant genes in triple-negative breast cancer. Genes Chromosomes Cancer47: 490–499. ArticleCASPubMed Google Scholar
He X, Duan C, Chen J, Ou-Yang X, Zhang Z, Li C et al. (2009). Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells. FEBS Lett583: 3501–3507. ArticleCASPubMed Google Scholar
Hopfner R, Mousli M, Jeltsch JM, Voulgaris A, Lutz Y, Marin C et al. (2000). ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression. Cancer Res60: 121–128. CASPubMed Google Scholar
Ishimura A, Terashima M, Kimura H, Akagi K, Suzuki Y, Sugano S et al. (2009). Jmjd2c histone demethylase enhances the expression of Mdm2 oncogene. Biochem Biophys Res Commun389: 366–371. ArticleCASPubMed Google Scholar
Italiano A, Attias R, Aurias A, Perot G, Burel-Vandenbos F, Otto J et al. (2006). Molecular cytogenetic characterization of a metastatic lung sarcomatoid carcinoma: 9p23 neocentromere and 9p23-p24 amplification including JAK2 and JMJD2C. Cancer Genet Cytogenet167: 122–130. ArticleCASPubMed Google Scholar
Katoh M . (2004). Identification and characterization of JMJD2 family genes in silico. Int J Oncol24: 1623–1628. CASPubMed Google Scholar
Kim JK, Esteve PO, Jacobsen SE, Pradhan S . (2009). UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells. Nucleic Acids Res37: 493–505. ArticleCASPubMed Google Scholar
Klose RJ, Zhang Y . (2007). Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol8: 307–318. ArticleCASPubMed Google Scholar
Kohno T, Otsuka A, Girard L, Sato M, Iwakawa R, Ogiwara H et al. (2010). A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene. Genes Chromosomes Cancer49: 342–352. CASPubMedPubMed Central Google Scholar
Kurowska-Stolarska M, Hueber A, Stolarski B, McInnes IB . (2011). Interleukin-33: a novel mediator with a role in distinct disease pathologies. J Intern Med269: 29–35. ArticleCASPubMed Google Scholar
Liu G, Bollig-Fischer A, Kreike B, van de Vijver MJ, Abrams J, Ethier SP et al. (2009). Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene28: 4491–4500. ArticleCASPubMedPubMed Central Google Scholar
Loh YH, Zhang W, Chen X, George J, Ng HH . (2007). Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev21: 2545–2557. ArticleCASPubMedPubMed Central Google Scholar
Mori T, Li Y, Hata H, Ono K, Kochi H . (2002). NIRF, a novel RING finger protein, is involved in cell-cycle regulation. Biochem Biophys Res Commun296: 530–536. ArticleCASPubMed Google Scholar
Mosmann T . (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods65: 55–63. ArticleCASPubMed Google Scholar
Natrajan R, Lambros MB, Rodriguez-Pinilla SM, Moreno-Bueno G, Tan DS, Marchio C et al. (2009). Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Clin Cancer Res15: 2711–2722. ArticleCASPubMed Google Scholar
Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T et al. (2006). A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell10: 515–527. ArticleCASPubMedPubMed Central Google Scholar
Northcott PA, Nakahara Y, Wu X, Feuk L, Ellison DW, Croul S et al. (2009). Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet41: 465–472. ArticleCASPubMedPubMed Central Google Scholar
Ostman A, Hellberg C, Bohmer FD . (2006). Protein-tyrosine phosphatases and cancer. Nat Rev Cancer6: 307–320. ArticlePubMed Google Scholar
Pole JC, Courtay-Cahen C, Garcia MJ, Blood KA, Cooke SL, Alsop AE et al. (2006). High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation. Oncogene25: 5693–5706. ArticleCASPubMed Google Scholar
Qian C, Li S, Jakoncic J, Zeng L, Walsh MJ, Zhou MM . (2008). Structure and hemimethylated CpG binding of the SRA domain from human UHRF1. J Biol Chem283: 34490–34494. ArticleCASPubMedPubMed Central Google Scholar
Rottach A, Frauer C, Pichler G, Bonapace IM, Spada F, Leonhardt H . (2010). The multi-domain protein Np95 connects DNA methylation and histone modification. Nucleic Acids Res38: 1796–1804. ArticleCASPubMed Google Scholar
Rui L, Emre NC, Kruhlak MJ, Chung HJ, Steidl C, Slack G et al. (2010). Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell18: 590–605. ArticleCASPubMedPubMed Central Google Scholar
Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS . (2010). A census of amplified and overexpressed human cancer genes. Nat Rev Cancer10: 59–64. ArticleCASPubMed Google Scholar
Shi Y, Whetstine JR . (2007). Dynamic regulation of histone lysine methylation by demethylases. Mol Cell25: 1–14. ArticleCASPubMed Google Scholar
Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T . (1992). Characterization of 21 newly established esophageal cancer cell lines. Cancer69: 277–284. ArticleCASPubMed Google Scholar
Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science314: 268–274. ArticlePubMed Google Scholar
Solomon DA, Kim JS, Cronin JC, Sibenaller Z, Ryken T, Rosenberg SA et al. (2008). Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma. Cancer Res68: 10300–10306. ArticleCASPubMedPubMed Central Google Scholar
Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P et al. (2006). Histone demethylation by a family of JmjC domain-containing proteins. Nature439: 811–816. ArticleCASPubMed Google Scholar
Unoki M, Brunet J, Mousli M . (2009). Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis. Biochem Pharmacol78: 1279–1288. ArticleCASPubMed Google Scholar
Veeriah S, Brennan C, Meng S, Singh B, Fagin JA, Solit DB et al. (2009). The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proc Natl Acad Sci USA106: 9435–9440. ArticleCASPubMedPubMed Central Google Scholar
Vinatzer U, Gollinger M, Mullauer L, Raderer M, Chott A, Streubel B . (2008). Mucosa-associated lymphoid tissue lymphoma: novel translocations including rearrangements of ODZ2, JMJD2C, and CNN3. Clin Cancer Res14: 6426–6431. ArticleCASPubMed Google Scholar
Vogelstein B, Kinzler KW . (2004). Cancer genes and the pathways they control. Nat Med10: 789–799. ArticleCASPubMed Google Scholar
Wang J, Zhang M, Zhang Y, Kou Z, Han Z, Chen DY et al. (2010). The histone demethylase JMJD2C is stage-specifically expressed in preimplantation mouse embryos and is required for embryonic development. Biol Reprod82: 105–111. ArticleCASPubMed Google Scholar
Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z et al. (2006). Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell125: 467–481. ArticleCASPubMed Google Scholar
Yang ZQ, Albertson D, Ethier SP . (2004). Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines. Cancer Genet Cytogenet155: 57–62. ArticleCASPubMed Google Scholar
Yang ZQ, Imoto I, Fukuda Y, Pimkhaokham A, Shimada Y, Imamura M et al. (2000). Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res60: 4735–4739. CASPubMed Google Scholar
Yang ZQ, Liu G, Bollig-Fischer A, Giroux CN, Ethier SP . (2010). Transforming properties of 8p11-12 amplified genes in human breast cancer. Cancer Res70: 8487–8497. ArticleCASPubMedPubMed Central Google Scholar
Yang ZQ, Streicher KL, Ray ME, Abrams J, Ethier SP . (2006). Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res66: 11632–11643. ArticleCASPubMed Google Scholar